From homes to cars and from boats to private jets there are many platforms designed to let owners share the pricey assets with others for profit.
Did you collect coins, rocks or comic books as a child? Dig your childhood collections out of the closet and see what they're worth now.
With savings interest rates at rock bottom, Pez dispensers or decoy ducks might be a better investment. Here's a fun way to pursue a little better return.
After I got married, we started buy rental homes. Then we added managing properties for other investors. We'll own five houses free and clear when I'm 47.
Some of today's financial products resemble the murder holes of medieval times in that you are almost guaranteed to lose if you get caught in one.
Only time will tell if gold gains regains its luster after a couple of years of unpolished performance.
Three childhood friends turn California dreaming into a fledgling business involving yerba mate, a traditional energy-booting tea.
Most investors think they have a self-directed IRA when in fact they have one that limits their investment choices. Do you know which one you have?
To diversify my assets and reduce my risk, I have always wanted to invest in real estate. To avoid landlord hassles, I chose REITs and empty land.
Billionaires have often been industrialists, real estate moguls or technology pioneers, but James Simons began his path to riches using math.
Lunar Mission One is offering to send your digital memory (or even your DNA) to the moon to be stored for a billion years.
Gold is at a more than 4-year low. How are its investors -- who are often older -- faring, and what can they expect?
You know about home equity loans, which let you borrow against your house. Now you can sell part of your home's possible future appreciation for cash today.
An Apple computer that co-founder Steve Jobs sold out of his parents' garage in 1976 for $600 will soon hit the auction block and could fetch a fortune.
A Web domain speculation company hopes to sell ebola.com for $150,000, but so far, it looks like no one in the pharmaceutical industry is likely to buy.